In a report issued Tuesday, Morgan Stanley downgraded its rating of Molycorp, Inc. MCP to Underweight with a target price of $2.50.
Paretosh Misra of Morgan Stanley sees that with investor confidence in Molycorp falling that there is very unattractive risk/reward and a 12 percent downside in their target for the company.
Misra does however see that with a "sharp" ramp-up in production Molycorp could cut their downside.
Even in light of the downgrade, shares of Molycorp are trading up 2.11 percent to $2.91 at last checked trade on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.